Toolgen

Developer of Gene therapies by using CRISPR- Cas9

placeSeoul, Seoul, South Korea calendar_todayFounded 1999 groups81 employees language toolgen.com

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Private equity120%
Other / undisclosed240%
Coming soon